Implantable Cardiac Monitors Market Anticipated to Grow at an Impressive Rate during the Period

Improved diagnostics and the availability of new monitoring devices have revolutionized the field of medical diagnostics in the last few decades. In addition, the development of sophisticated devices in the field of medical cardiology and the increasing adoption of both hospital and home care is crucial to market growth.

The Global Implantable Cardiac Monitors Market was valued at $410.4 million in 2016 and is projected to reach $678.3 million by 2023, growing at a CAGR of 7.4% from 2017 to 2023. The cardiac arrhythmias indication accounted for nearly half of the market share in 2016.

Implantable heart monitors help doctors assess the health status of the patient's heart rhythm. These devices help treat the heart patient and ensure the patient's heart function.

They are used to monitor several serious heart conditions, including heart failure, atrial fibrillation, and signs of recent heart attacks. With the increased use of advanced batteries with durable battery life, patients can be continuously monitored for almost 2-3 years with the help of an implantable loop recorder or heart monitor. Therefore, these devices are ideal for patients who need continuous monitoring over a long period of time.

Request Sample Report at https://www.alliedmarketresearch.com/request-sample/4517

The report provides a comprehensive analysis of the key players operating in the global implantable cardiac monitors market such as Abbott Laboratories,
o Biotronik SE & Co. KG,
o Boston Scientific Corporation,
o Edwart,
o General Electric Company,
o Koninklijke Philips N.V.,
o LivaNova PLC,
o Medtronic plc,
o Nihon Kohden Corporation
o Phoenix Heart Center

The other players of the global implantable cardiac monitors market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., ReliantHeart Inc., Abiomed, Inc., Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.

Technological advancements in cardiac monitoring devices, awareness among patients about monitoring of the heart & treatment options for management of cardiac disorders, and high unmet medical needs in developing & underdeveloped regions of the world are projected to drive the market growth.

However, limited insurance coverage, inflated cost of devices, and preference for drugs over treatment devices are the factors expected to restrain the market growth. Conversely, the presence of favorable government initiatives and contributions from independent organizations are anticipated to offer several opportunities for market growth.

The atrial fibrillation occupied about one-third share of the total implantable cardiac monitors market in 2016 and is expected to retain its position throughout the forecast period.

The hospital's segment accounted for about two-thirds of the market share in 2016 and is anticipated to maintain its dominance during the forecast period. This is attributed to the high usage of cardiac monitoring devices in hospitals for acute care, nonacute care, and nontreatment purposes.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4517

KEY FINDINGS OF THE STUDY
o Epilepsy & unexplained falls are anticipated to grow at a steady rate during the analysis period.
o The U.S. was the major shareholder in the North American implantable cardiac monitors market, accounting for the highest share in 2016.
o China occupied a one-sixth share of the total Asia-Pacific implantable cardiac monitors market in 2016 and is expected to register a CAGR of 9.4% from 2017 to 2023.
o The cardiac centers & clinics segment witnessed the highest growth and is anticipated to grow at a CAGR of 8.4% from 2017 to 2023.
o In terms of volume, the global implantable cardiac monitors market is forecasted to reach 261 thousand units by 2023 at a CAGR of 10.3% from 2017-2023.

In 2016, Asia-Pacific and LAMEA collectively accounted for a nearly one-fifth share of the market, and are expected to continue this trend throughout the forecast period. An increase in awareness regarding cardiac monitoring; availability of cardiac monitors specifically in China, India, and the other developing economies and surge in prevalence of the cardiac diseases drive the market growth. Moreover, the massive target population and growth in the economy catering to the establishment of healthcare facilities boost the growth of the market.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.